50 attendees - 20 nations 20 leaders of vitiligo organizations from all over the world,…
Thando Ngwenya9 June 2022
Tags
Categories
Recent Posts
- FDA Approves New Vitiligo Treatment, Ruxolitinib (Opzelura) The JAK inhibitor cream is the first medication that can restore pigment in people with this autoimmune disease.
- 3RD VIPOC CONFERENCE 21ST-23RD APRIL 2022 AMSTERDAM (THE NETHERLANDS)
- Anxiety and depression in pediatric patients with vitiligo and alopecia areata and their parents: A cross-sectional controlled study Part 2
- Factors affecting quality of life in patients with vitiligo Part 2
- Painful process and rebirth of turning ‘white’
-
FDA Approves New Vitiligo Treatment, Ruxolitinib (Opzelura) The JAK inhibitor cream is the first medication that can restore pigment in people with this autoimmune disease. 27 July 2022 -
3RD VIPOC CONFERENCE 21ST-23RD APRIL 2022 AMSTERDAM (THE NETHERLANDS) 9 June 2022 -
Anxiety and depression in pediatric patients with vitiligo and alopecia areata and their parents: A cross-sectional controlled study Part 2 4 May 2022
